NDC 11695-4013 - DexaJect SP
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11695-4013
- Package NDCs from labels
- 11695-4013-1
- Manufacturer
- Butler Animal Health Supply, LLC, D/B/A/ Henry Schein Animal Health | Bimeda, Inc. | Bimeda-MTC | Sanofi Chimie | Pharmacia and Upjohn Company LLC
- Effective date
- 2019-01-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Sodium Phosphate 4mg Injection | Butler Animal Health Supply, LLC, D/B/A/ Henry Schein Animal Health | Bimeda, Inc. | Bimeda-MTC | Sanofi Chimie | Pharmacia and Upjohn Company LLC | 2019-01-02 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| dexamethasone sodium phosphate | ACTIVE INGREDIENT | AI9376Y64P | DEXAJECT SP (DEXAMETHASONE SODIUM PHOSPHATE 4MG INJECTION) INJECTION [HENRY SCHEIN ANIMAL HEALTH, BUTLER ANIMAL HEALTH] | 6 | |
| dexamethasone | ACTIVE MOIETY | 7S5I7G3JQL | DEXAJECT SP (DEXAMETHASONE SODIUM PHOSPHATE 4MG INJECTION) INJECTION [HENRY SCHEIN ANIMAL HEALTH, BUTLER ANIMAL HEALTH] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 8969803e-2e45-1f28-e053-2995a90a05a7 | 2023-05-15 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | bbf0f0ee-1891-4f3d-e053-2a95a90a5e18 | 2023-05-04 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 9f69846e-5897-c301-e053-2a95a90a44f1 | 2023-05-03 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 667323ea-5a5e-3465-e053-2a91aa0a1667 | 2023-04-26 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | 2d96d5e8-00bf-406b-b345-f1c31865fe94 | 2023-04-04 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 94cb045b-5801-db32-e053-2a95a90a93ef | 2022-12-10 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | ca762fbf-6bf5-4b39-8f40-3fb5f1f77778 | 2022-10-12 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Bausch & Lomb Incorporated | 6bdcefbe-51e3-4ca4-afda-5aeca7b6fa73 | 2022-08-31 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | b2ce414a-3b1f-4533-bb3a-18594529dead | 2020-11-25 | Warnings, Adverse reactions | AI9376Y64P |
| DMT SUIK | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | a7b7884a-6bd4-4d06-8f14-0759450c0724 | 2020-06-17 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Mylan Institutional LLC | 836f8017-d023-410b-8515-ec776e73ca59 | 2019-11-04 | Warnings, Adverse reactions | AI9376Y64P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.